Proving and measuring AI ROI

Now in its 3rd year, the AI in Capital Markets Summit returns to London with a sharper focus on what it really takes to deploy AI safely and at scale and to prove measurable return on investment. While AI offers enormous potential to transform trading, risk, compliance and operations, many firms are still struggling to move beyond departmental pilots into enterprise platforms that deliver consistent business value.

The AI in Capital Markets Summit will explore the practitioner roadmap for scaling AI across the front, middle and back office with a focus on real world use cases sharing lessons learned and metrics for ROI. You’ll gain practical insight into building repeatable AI ROI frameworks that stand up to CFO scrutiny, quantifying value through risk reduction and efficiency gains, and embedding Model Risk Management, explainability and audit trails into GenAI and agentic systems.

Join senior leaders from across the Buy Side and Sell Side to learn how to operationalise AI responsibly, secure your organisation against emerging threats such as deepfakes and AI-enabled attacks, and prepare for the next wave of innovation from multimodal AI to quantum computing.

2026 Topics:

• Proving AI ROI: repeatable frameworks for cost, revenue and risk reduction
• Enterprise AI strategy: moving from pilots to firm wide platforms and Agentic AI
• Safe, scalable AI deployment: control planes, guardrails, kill-switches and AgentOps
• Data readiness for AI: standardised data models, quality, lineage and fragmentation
• Smart data fabric and RAG: unifying structured and unstructured data for decision intelligence
• Real-time surveillance and anomaly detection: reducing false positives with auditable AI
• Regulatory compliance and model risk governance: explainability, audit trails and accountability
• Security, privacy and ethical AI: deepfakes, AI-enabled threats, bias mitigation and resilience
• Future-focused innovation: quantum computing and next-wave AI for capital markets

Please note this event is being run under Chatham House Rules.